Furlan, Ingrid <br/><br/>
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.  [electronic resource] 

 -  Blood  Mar 2009 
 - 2867-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2008-12-195693  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Azacitidine--pharmacology<br/>Bone Marrow Cells--ultrastructure<br/>Calcitonin--genetics<br/>Chromosomes, Human, Pair 7<br/>Clone Cells--ultrastructure<br/>Combined Modality Therapy<br/>CpG Islands<br/>DNA Methylation--drug effects<br/>Genes, ras<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Infant<br/>Leukemia, Myelomonocytic, Juvenile--drug therapy<br/>Male<br/>Monosomy<br/>Neoplasm Proteins--genetics<br/>Point Mutation<br/>Promoter Regions, Genetic<br/>Protein Precursors--genetics<br/>Remission Induction